PCH
RVNC

Polar Capital Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History

Polar Capital Holdings’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,567,139
Closed -$9.17M – 317
2024
Q2 		$9.17M Sell
3,567,139
-317,680
-8% -$1.08M 0.05% 192
2024
Q1 		$19.1M Buy
3,884,819
+715,580
+23% +$4.24M 0.1% 149
2023
Q4 		$27.9M Sell
3,169,239
-991,072
-24% -$8.12M 0.17% 113
2023
Q3 		$47.7M Sell
4,160,311
-7,531
-0.2% -$145K 0.35% 77
2023
Q2 		$105M Hold
4,167,842
– – 0.53% 37
2023
Q1 		$134M Sell
4,167,842
-680,791
-14% -$21.2M 0.87% 24
2022
Q4 		$89.5M Buy
4,848,633
+386,886
+9% +$8.85M 0.71% 39
2022
Q3 		$120K Buy
4,461,747
+1,344,695
+43% +$27.3M 0.77% 25
2022
Q2 		$43.1K Buy
3,117,052
+660,555
+27% +$10.2M 0.25% 86
2022
Q1 		$47.9K Buy
2,456,497
+196,797
+9% +$2.98M 0.22% 99
2021
Q4 		$36.9K Buy
2,259,700
+516,703
+30% +$8.61M 0.14% 123
2021
Q3 		$48.6K Buy
1,742,997
+588,263
+51% +$16.8M 0.2% 109
2021
Q2 		$34.2K Hold
1,154,734
– – 0.15% 123
2021
Q1 		$32.3M Hold
1,154,734
– – 0.2% 123
2020
Q4 		$32.7M Buy
+1,154,734
New +$29.9M 0.2% 117

Other funds holding RVNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Polar Capital Holdings's RVNC Position: Q3 2024 in Review

Polar Capital Holdings sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2024, closing a stake of 3,567,139 shares — an estimated $9.17M sold.

Polar Capital Holdings first reported a position in RVNC in Q4 2020 and held it in 15 quarters. The position peaked at $134M in Q1 2023. 201 funds tracked by Wall St. Rank hold RVNC as of Q3 2024.

  • Polar Capital Holdings reported no remaining Revance Therapeutics, Inc. position as of Q3 2024 after selling out during the quarter.
  • Polar Capital Holdings sold 3,567,139 Revance Therapeutics, Inc. shares in Q3 2024, an estimated $9.17M.
  • Polar Capital Holdings first reported a position in Revance Therapeutics, Inc. in Q4 2020 and held it in 15 quarters.
  • Polar Capital Holdings's Revance Therapeutics, Inc. position peaked at $134M in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2024.

Based on Polar Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.